EFMODY is a prescription medication specifically designed for the treatment of congenital adrenal hyperplasia (CAH) in patients aged 12 years and older. CAH is a group of genetic conditions that affect the adrenal glands, leading to a deficiency in certain hormones and an overproduction of others, such as androgens. EFMODY, with its active ingredient hydrocortisone modified-release capsules, works by mimicking the natural circadian rhythm of cortisol when taken as directed, helping to manage the hormone imbalance. This innovative approach aims to improve the quality of life for individuals with CAH by reducing the symptoms associated with cortisol deficiency and androgen excess, such as abnormal growth and development, infertility, and physical stress.